InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,995.54
(
0.38%
)
US TECH 100
20,562.00
(
0.10%
)
Dow Jones
43,988.99
(
0.59%
)
Brent Oil
73.89
(
0.00%
)
Bitcoin
77,852.65
(
1.40%
)
Post# of 4764
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biophud

Send PM Follow Ignore
Followers 0
Posts 394
Boards Moderated 0
Alias Born 08/12/2006

biophud

Re: Imclonian post# 2892

Saturday, 12/09/2006 12:09:30 PM

Saturday, December 09, 2006 12:09:30 PM

Post# of 4764
Clinical trial results will provide the ultimate answer. I consider it positive that the NCI is running such a trial. NCI sponsorship means little/no cost for Imclone, and also suggests a strong scientific rational for the combo.

Two Points

1. I would expect combined Erbitux + Tarceva to have bad skin/rash side effects.
2. With combo targeted therapies (like Erbitux and Tarceva) it may be possible to limit or eliminate chemotherapy, and all of its bad side effects.

Have a good weekend,

biophud
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up